Global Trends in Monoclonal Antibodies Industry Highlighted with Competitive, Technological and R&D Landscape
Albany, US, 2017-Nov-14 — /EPR Network/ — Antibodies are increasingly becoming the preferred choice to treat several disorders such as respiratory diseases, oncology, and autoimmune diseases. [read full press release…]
